KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $1,407 | $847 | $1,192 | $1,082 |
| - Cash | $175 | $201 | $238 | $54 |
| + Debt | $3 | $3 | $44 | $47 |
| Enterprise Value | $1,234 | $648 | $998 | $1,074 |
| Revenue | $23 | $19 | $17 | $15 |
| % Growth | 16.5% | 12.4% | 14.2% | – |
| Gross Profit | $11 | $9 | $8 | $7 |
| % Margin | 50.6% | 45.7% | 44.3% | 43.4% |
| EBITDA | -$28 | -$22 | -$47 | -$18 |
| % Margin | -126.2% | -112.8% | -275.1% | -119.7% |
| Net Income | -$33 | -$26 | -$52 | -$22 |
| % Margin | -145.3% | -133.3% | -302.1% | -142.5% |
| EPS Diluted | -0.64 | -0.5 | -2.21 | -0.5 |
| % Growth | -28% | 77.4% | -342% | – |
| Operating Cash Flow | -$18 | -$26 | -$24 | -$18 |
| Capital Expenditures | -$7 | -$8 | -$8 | -$4 |
| Free Cash Flow | -$26 | -$34 | -$32 | -$22 |